Syneos Health, LLC, a leading biopharmaceutical solutions organisation headquartered in the United States, has been at the forefront of the healthcare industry since its founding in 2018. With a strong presence in North America, Europe, and Asia, Syneos Health offers a unique blend of clinical and commercial services designed to accelerate the delivery of innovative therapies to market. The company specialises in providing integrated solutions that encompass clinical development, commercialisation, and consulting services. Syneos Health distinguishes itself through its commitment to harnessing data and technology, enabling clients to navigate the complexities of drug development efficiently. Recognised for its strategic approach, the company has achieved significant milestones, positioning itself as a trusted partner for biopharmaceutical companies worldwide.
How does Syneos Health, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Syneos Health, LLC's score of 41 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Syneos Health, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Syneos Health, Inc., which may influence its climate commitments and initiatives. While there are no documented reduction targets or specific climate pledges from Syneos Health, LLC, it is important to note that any climate-related initiatives or targets may be inherited from its parent company, Syneos Health, Inc. This relationship suggests that Syneos Health, LLC may align with broader corporate sustainability goals set by its parent organisation. As of now, without specific emissions data or reduction targets, Syneos Health, LLC's climate commitments remain unclear. The company may still be in the process of developing its own strategies to address carbon emissions and contribute to climate action within the biopharmaceutical industry.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Syneos Health, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.